Skip to main content
Logo Clarunis

Dr. med. Michael Manz

Konsiliararzt Gastroenterologie/Hepatologie
Standort Claraspital

 

Portrait
Portrait
Lebenslauf
Publikationen
Lebenslauf

Seit 2024
Konsiliararzt Gastroenterologie/Hepatologie, Clarunis – Universitäres Bauchzentrum Basel

06/2016 - 2024
Stv. Chefarzt Gastroenterologie Bauchzentrum St. Claraspital Basel (Prof. M. von Flüe/PD Dr. M. Thumshirn)

04/2012 - 05/2016
Leitender Arzt Gastroenterologie Bauchzentrum St. Claraspital Basel (Prof. M. von Flüe/PD Dr. M. Thumshirn)

1/2012 - 3/2012
Oberarzt Gastroenterologie Bauchzentrum St. Claraspital Basel (Prof. M. von Flüe/PD Dr. M. Thumshirn)

2010 - 2011
Oberarzt Gastroenterologie und Innere Medizin, Abteilung für Innere Medizin und Gastroenterologie, St. Claraspital Basel (Prof. Ch. Ludwig/PD Dr. M. Thumshirn)

2009
Fähigkeitsausweis ERCP

2008 - 2010
Oberarzt Gastroenterologie, Abteilung für Gastroenterologie und Hepatologie, Universitätsspital Basel (Prof. Ch. Beglinger)

2008
Facharzt FHM für Gastroenterologie

2007 - 2008
Assistenzarzt Gastroenterologie, Abteilung für Gastroenterologie und Hepatologie, Universitätsspital Basel (Prof. Ch. Beglinger)

2006
Facharzt FHM für Innere Medizin

2005 - 2007
Assistenzarzt Gastroenterologie, Medizinische Universitätsklinik, Kantonsspital Liestal (Prof. R. Meier)

2002 - 2005
Assistenzarzt Medizinische Universitätsklinik, Kantonsspital Bruderholz (Prof. R. Krapf)

2001
Promotion Universität Basel: «Die Prognose der veralteten Monteggialäsion», (Prof. L. von Laer, Universitätskinderspital Basel)

2000 - 2002
Assistenzarzt Chirurgische Klinik, St. Claraspital Basel (Prof. P. Tondelli)

2000
Praxisassistenz und Vertretung, Dr. M. Büttler, Innere Medizin, Kerns

1999
Eidgenössisches Arztdiplom

1993 - 1999
Studium der Humanmedizin an der Universität Basel

Publikationen
  • Burri E, Maillard MH, Schoepfer AM, Seibold F, Van Assche G, Rivière P, Laharie D, Manz M; Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. Treatment Algorithm for Mild and Moderate-to-Severe Ulcerative Colitis: An Update. Digestion. 2020;101 Suppl 1:2-15. doi: 10.1159/000504092. Epub 2020 Jan 16. PMID: 31945767.
  • Juillerat P, Manz M, Sauter B, Zeitz J, Vavricka SR; Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology. Therapies in Inflammatory Bowel Disease Patients with Extraintestinal Manifestations. Digestion. 2020;101 Suppl 1:83-97. doi: 10.1159/000502816. Epub 2020 Feb 17. PMID: 32066137.
  • Burri E, Juillerat P, Maillard MH, Manz M, Michetti P, Mottet C, Rogler G, Zahnd N, Vavricka S. Position statement on the use of biosimilars in inflammatory bowel disease. Swiss Med Wkly. 2019 Dec 2;149:w20148. doi: 10.4414/smw.2019.20148. PMID: 31800086.
  • Winkler W, Manz M, Sauter M. Akute Pankreatitis. Swiss Medical 2018; 18(40): 810-816
  • Gruber M., Füglistaler I., Zettel A., Fox M., Manz M.: An Unusual Cause of Rectal Stenosis. Case Rep Gastroenterol. 9 Aug 2016: 10(2): 406–409
  • Urban S., Manz M., Zettl A., Peters T., Baumann K., von Flüe M.: Gastric Ulcer: An Old Disease – A New Cause. J Gastrointest Dig Syst. Nov 2014: 4: 6
  • Zumstein V., Bolli M., Manz M.: Lighting on PET Scan-Not Always Cancer. J Gastrointest Dig Syst. Jan 2015: 5: 1
  • Schulte F., Manz M.: Colitis ulzerosa – aktuelle Diagnostik und Therapie. Hausarzt Praxis. April 2015: 10(4): 16–20
  • Burri E., Manz M., Schroeder P., Froehlich F., Rossi L., Beglinger C., Lehmann F.S.: Diagnostic yield of endoscopy in patients with abdominal complaints: incremental value of faecal calprotectin on guidelines of appropriateness. BMC Gastroenterol. 2014.
  • Manz M., Schoepfer A.M.: Therapie der CED bei Steroidversagen. Immunsuppressiva oder Biologika? Gastroenterologe 8, April 2013: 205–210.
  • Vavricka S., Sulz M., Degen L., Rechner R., Manz M., Biedermann L., Beglinger C., Peter S., Safroneeva E., Rogler G., Schoepfer A.: Monitoring colonoscopy withdrawal time significantly improves the adenoma detection rate and the Performance of endoscopists. Endoscopy. Mar 2016: 48(3): 256–262
  • Burri E., Manz M., Rothen C., Rossi L., Beglinger C., Lehmann F.S.: Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort. Clin Chim Acta. 2013 Feb 1; 416: 41–47.
  • Burri E, Manz M, Rothen C, Rossi L, Beglinger C, Lehmann FS. Monoclonal antibody testing for faecal calprotectin is superior to polyclonal testing of faecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort. Clin Chim Acta. 2012 [Epub ahead of print]
  • Frei P, Biedermann L, Manser CN, Wilk M, Manz M, Vavricka SR, Rogler G. Topical therapies in inflammatory bowel disease. Digestion 2012;86 Suppl 1:36-44.
  • Manz M, Vavricka SR, Wanner R, Lakatos PL, Rogler G, Frei P, Safroneeva E, Schoepfer AM. Therapy of steroid-resistant inflammatory bowel disease. Digestion. 2012;86 Suppl 1:11-5.
  • Girardin M, Manz M, Manser C, Biedermann L, Wanner R, Frei P, Safroneeva E, Mottet C, Rogler G, Schoepfer AM. First-line therapies in inflammatory bowel disease. Digestion. 2012;86 Suppl 1:6-10.
  • Blaich A, Manz M, Dumoulin A, Schüttler CG, Hirsch HH, Gerlich WH, Frei R. Reactivation of hepatitis B virus with mutated hepatitis B surface antigen in a liver transplant recipient receiving a graft from an antibody to hepatitis B surface antigen- and antibody to hepatitis B core antigen-positive donor. Transfusion. 2012 Feb [Epub ahead of print]
  • Manz M, Burri E, Rothen C, Tchanguizi N, Niederberger C, Rossi L, Beglinger C, Lehmann FS. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. BMC Gastroenterol. 2012 Jan 10;12(1):5. [Epub ahead of print]
  • Burri E, Manz M, Rieder S, Beglinger C. Limited value of fecal calprotectin in patients with liver cirrhosis. Scand J Gastroenterol. 2011 Dec;46(12):1527-8.
  • Manz M, Michetti P, Seibold F, Rogler G, Beglinger C. Treatment algorithm for moderate to severe ulcerative colitis. Swiss Med Wkly. 2011.
  • Budweg J, Stettler L, Zettl A, Manz M. Manchmal lohnt sich ein zweiter Blick. Schweiz Med Forum 2011;11(13):239–240
  • Vavricka SR, Schoepfer AM, Bansky G, Binek J, Felley C, Geyer M, Manz M, Rogler G, de Saussure P, Sauter B, Scharl M, Seibold F, Straumann A, Michetti P; SwissIBDnet. Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey. Inflamm Bowel Dis. 2011.17(7):1530-9
  • Sawatzki M, Beglinger C, Lugli A, Manz M. Natürliche Chromoendoskopie. Swiss Medical Forum 2010; 10(7):139.
  • Schoepfer AM, Vavricka SR, Binek J, Felley CH, Geyer M, Manz M, Rogler G, De Saussure PH, Sauter B, Seibold F, Straumann A, Michetti P. Efficacy and Safety of Certolizumab Pegol Induction Therapy in an Unselected Crohn’s Disease Population: Results of the FACTS Survey. Inflammatory Bowel Diseases 2010 [Epub ahead of print].
  • Manz M, Schmeer T, Toia D, Meier R, Maurer CA. Bronchogenic Cyst: A Rare Cause of a Retroperitoneal Mass. Zentralbl Chir. 2009 May 7. [Epub ahead of print]
  • Vavricka SR, Burri E, Beglinger C, Degen L, Manz M. Serum Protein Electrophoresis: An Underused but Very Useful Test. Digestion. 2009 Apr 9;79(4):203-210.
  • Tapia C, Schneider T, Manz M. From Hyperkalemia to Ischemic Colitis: A Resinous Way. Clin Gastroenterol Hepatol. 2009 Aug;7(8):e46-7.
  • Manz M, Meier R. Chronische Obstipation. Ursachen, Diagnostik und Therapie. ARS Medici Nr. 7/2009. 287 - 281.
  • Vavricka SR, Manz M, Burri E. Trichuris trichiura (Whipworm). Clin Gastroenterol Hepatol. 2008 Dec 13. [Epub ahead of print]
  • Piccoli-Gfeller F, Beglinger C, Manz M. Chronic Diarrhea, Weight Loss, and Refractory Epilepsy 3 Years After Percutaneous Endoscopic Gastrostomy. Clin Gastroenterol Hepatol. 2009 Feb 26. [Epub ahead of print]
  • Manz M, Beglinger Ch, Vavricka SR. Fatal invasive pulmonary aspergillosis associated with adalimumab therapy.Gut. 2009; 58(1):149.
  • Manz M, Meier R. Chronische Obstipation. Schweiz Zschr Ernährungsmed 2008; 2, 29-34.
  • Manz M, Peter S, Beglinger C. An Atypical Approach to Appendicitis. Clin Gastroenterol Hepatol. 2008; 6(4):xx.
  • Manz M, Meier R, Schaub N, Toia D, Steuerwald M. Pseudodivertikulose des Ösophagus. Praxis 2007; 96(37): 1385-9.
  • Sulz MC, Manz M, Grob P, Meier R, Drewe J, Beglinger C. Comparison of two antacid preparations on intragastric acidity – A two center open randomised cross-over placebo-controlled trial. Digestion 2007; 75: 69-73.
  • Manz M, Meier R, Steuerwald M. Cameron Läsion. Schweiz Med Forum 2007; 7: 508.
  • Manz M, Meier R. Pharmakologische Therapie von Transitstörungen. Therapeutische Umschau 2007; 4: 227-32.
  • Manz M, Steuerwald M. Cryptosporidiosis in a patient on PEG-interferon and ribavirin for recurrent hepatitis C after living donor liver transplantation. Transplant Infectious Disease 2007; 9: 60-61.
  • Manz M, De Lorenzi D, Abdel-Latif A, Willi N, Berneis K. Symptomatic primary hyperparathyroidism with renal fornix rupture. The Endocrinologist 2005; 15: 317-319.
  • Ritter Ch, Manz M, Schultze D, Rothen M. HIV-assoziierte Polyradikuloneuropathie. Schweiz Med Forum 2005; 5: 368-70.
  • Scholer A, Zanetti A, Manz M, Von Dahlen R, Krapf R. Suizidversuch mit Bromazepam. Toxichem Krimtech 2003; 70: 61-64.